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Objectives: This study aims to compare the impact of two different sources of resource
use, self-report versus care provider registrations, on cost and cost utility.
Methods: Data were gathered for a cost-effectiveness study performed alongside a
2-year randomized controlled trial evaluating the effect of an INTERdisciplinary
COMmunity-based management program (INTERCOM) for patients with chronic
obstructive pulmonary disease (COPD). The program was offered by physiotherapists,
dieticians and respiratory nurses. During the 2-year period, patients reported all resource
use in a cost booklet. In addition, data on hospital admissions and outpatient visits, visits
to the physiotherapist, dietician or respiratory nurse, diet nutrition, and outpatient
medication were obtained from administrative records. The cost per quality-adjusted
life-year (QALY) was calculated in two ways, using data from the cost booklet or
registrations.
Results: In total, 175 patients were included in the study. Agreement between self-report
and registrations was almost perfect for hospitalizations (rho = 0.93) and physiotherapist
visits (rho = 0.86), but above 0.55, moderate, for all other types of care. The total cost
difference between the registrations and the cost booklet was 464 euros with the highest
difference for hospitalizations 386 euro. Based on the cost booklet the cost difference
between the treatment group and usual care was 2,444 euros (95 percent confidence
interval [CI], −819 to 5,950), which resulted in a cost-utility of 29,100 euro/QALY. For the
registrations, the results were 2,498 euros (95 percent CI, −88 to 6,084) and 29,390
euro/QALY, respectively.
Conclusions: This study showed that the use of self-reported data or data from
registrations effected within-group costs, but not between-group costs or the cost utility.
Keywords: Self-report, Registrations, Resource Use, Cost, Cost utility, COPD, Diary
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The impact of the data source on cost-utility
In cost-effectiveness studies performed alongside clinical
trials, healthcare utilization can be measured using ques-
tionnaires or diaries completed by the patients in the trial
or obtained from medical, billing, or other administrative
records. The latter is often regarded as more accurate than
the first. However, retrieving data from medical or admin-
istrative records can be time consuming and costly, espe-
cially when patients contact many different care providers.
Furthermore, data on services for which the patient pays
out-of-pocket, such as over-the-counter medication or alter-
native therapists, are missed using medical or administrative
records only. Self-reported surveys, such as questionnaires
or diaries, can provide data on all types of healthcare utiliza-
tion, but can be less valid due to recall-bias. Several studies
compared self-reported healthcare utilization with data from
medical records, but results are inconclusive. Some studies
found good agreement between both sources (9;13;18;20),
but others reported substantial differences (2;4;6). In general,
agreement seems fairly good on major events such as hos-
pitalizations or visits to the emergency department, but self-
report of outpatient visits, visits to the general practitioner,
and diagnostic, laboratory or imaging procedures seems less
valid compared with medical records (1;8;12;14;17). Al-
though several studies reported about the extent of agreement
between self-reported healthcare utilization and data from
medical records (1;4;8;12;18), the impact of the different
types of data collection on cost(-effectiveness) has not been
studied. This is an important issue, because almost perfect
agreement in hospitalizations between two data sources can
still result in a substantial difference in costs as a result of the
high costs of an inpatient day. On the other hand, a substantial
difference in visits to the general practitioner may have little
impact on costs, because of its low unit costs. The aim of this
study was to compare the impact of using either self-reported
resource use or resource use as obtained from administrative
data of healthcare providers on costs and cost-effectiveness
in a sample of patients with chronic obstructive pulmonary
disease (COPD). Furthermore, we explored whether differ-
ences in cost estimates between the two different types of
data sources were related to patient characteristics.
METHODS
Design of the Trial, the Intervention, and
the Cost-effectiveness Study
Data were obtained as part of a cost-effectiveness study per-
formed alongside a 2-year randomized controlled trial evalu-
ating the effect of an INTERdisciplinary COMmunity-based
COPD management program (INTERCOM) (7). The trial
included patients with COPD and impaired exercise perfor-
mance who were recruited from two general hospitals in
the Netherlands. One-hundred ninety-nine patients were ran-
domized to the INTERCOM program (n = 102) or usual care
(n = 97).
The INTERCOM program consisted of exercise train-
ing, education, and smoking cessation support offered by
local physiotherapists in the proximity of the patient’s home
and by respiratory nurses in the hospital. Nutritionally de-
pleted patients in the INTERCOM group were referred to
a local dietician for counseling and nutritional supplements
(Respifor R©). The program was divided in a 4-month inten-
sive intervention phase followed by a 20-month maintenance
phase. During the intensive intervention phase, all patients
visited the physiotherapist twice a week, the respiratory nurse
on average two times and the dietician four times if they were
nutritionally depleted. In the maintenance phase, these fre-
quencies were lower: once a month for the physiotherapist
and at 6, 9, 12, and 24 months for the dietician. Visits to the
respiratory nurse during the maintenance phase were upon
request and varied widely between patients from 0 to 16 vis-
its. Patients assigned to usual care received pharmacotherapy
according to accepted guidelines, a short smoking cessation
advice by their respiratory physician and short nutritional
advice to eat more and better in case they were nutritionally
depleted. Quality of life and several functional parameters
were assessed at baseline, 4, 12, and 24 months. All patients
gave written informed consent.
The cost-effectiveness study was conducted from a soci-
etal perspective including all COPD and non-COPD-related
healthcare costs, travel expenses, and costs of productivity
losses. All costs related to conducting the trial have been ex-
cluded. Health outcomes were expressed in terms of quality-
adjusted life-years gained (QALYs), using EQ-5D utility
values.
Self-report Versus Care Provider
Registrations of Resource Use
During the whole 2-year study period, healthcare utiliza-
tion was recorded weekly in a cost booklet. In this book-
let, patients recorded visits to general practitioners, medical
specialists, physiotherapists, dieticians, respiratory nurses,
alternative therapists, psychologists, social workers, use of
over-the-counter medication and medical devices, hospital
admissions, ambulance rides, time lost from paid work, hours
of (un)paid household help, number of units of Respifor R©
used and use of other nutritional supplements. For all visits
to care providers, the travel distance was recorded to be able
to calculate travel expenses. Each booklet covered a period
of 4 weeks and was collected every 2 months. In case the
recorded information was unclear, patients were contacted
by the investigators by telephone for further clarification.
Next to the self-reported data from the cost booklet,
resource use was obtained from administrative data of dif-
ferent care providers. Information on the delivery and costs
of outpatient medication was obtained from the patients’ lo-
cal pharmacies. For twelve patients using oxygen, the start
and stop dates of oxygen supply were obtained from their
oxygen supplier. The number of hospitalizations, inpatient
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Table 1. Mean Resource Use per Patient and Correlations between Self-report and Care Provider Registrations for the
Complete 2-Year Study Period before Multiple Imputation of Missing Data (n = 175)
Care provider Self-reported
registrations cost booklet
No. of Absolute Spearman rank Percentage of
Hospital patients Mean Missinga Mean Missinga difference correlation coefficient perfect agreement
Daycare treatment 175 0.25 6.0% 0.08 4.5% 0.17 0.55 87
Daycare treatment for COPD 175 0.035 6.0% 0.006 4.5% 0.03 0.49 98
Hospital admissions 175 0.79 6.0% 0.69 4.5% 0.10 0.93 88
Hospital admissions for COPD 175 0.36 6.0% 0.33 4.5% 0.03 0.94 95
Total hospital days 175 8.0 6.0% 6.6 4.5% 1.4 0.91 79
Total hospital days for COPD 175 4.3 6.0% 3.6 4.5% 0.7 0.93 93
Visits to medical specialists 175 10.5 6.0% 9.2 4.5% 1.3 0.70 8
Visits to the physiotherapistb 87 48.4 5.7% 49.9 6.4% −1.4 0.86 7
Visits to the respiratory nurseb 87 7.5 5.7% 5.1 6.4% 2.4 0.65 11
Visits to the dietician c 21 8.1 2.7% 6.6 2.7% 1.5 0.64 29
Units Respifor R© used c 21 491 2.7% 461 2.7% 30 0.68 10
aThe percentage of missingness was calculated as the total number of weeks with missing data summed over all patients divided by the maximum number
of observable weeks if all patients had complete data for the entire 2-year study period (=18200).
bOnly applicable to patients in the INTERCOM group,
cOnly applicable to nutritionally depleted patients in the INTERCOM group.
COPD, chronic obstructive pulmonary disease.
hospital days, and outpatient visits to medical specialists
were obtained from the administrative systems of the two
hospitals in the study. All seventeen local physiotherapists
who treated patients in the INTERCOM group provided in-
formation about the number of contacts, the date, duration
of the visits, and whether treatment was for the INTERCOM
study or not. The six respiratory nurses involved in the study
provided the same information for outpatient visits to the
respiratory nurses for all patients in the INTERCOM group.
The five local dieticians who treated nutritionally depleted
patients in the INTERCOM group provided detailed infor-
mation about the visits to the dietician. Finally, the number of
units of Respifor R© supplied to all nutritionally depleted pa-
tients in the treatment group was obtained from the supplier
(Nutricia Netherlands).
Resource utilization was valued using Dutch guideline
prices updated to the year 2007 (11). More details about the
cost calculation and the cost per unit used can be found else-
where (7), but the most important unit costs are summarized
in the online appendix (Supplementary Table 1, which can
be viewed online at www.journals.cambridge.org/thc).
Two Different Estimates of Cost-Utility
Cost-utility was calculated in two different ways. In the first
analysis, data on healthcare utilization were based entirely
on self-reported data from the cost booklet. Only data on
outpatient medication and oxygen use were obtained from
registrations as no self-reported data were available.
In the second analysis, data on healthcare utilization
were based on registrations. This implied that outpatient
medication, oxygen use, hospitalizations and visits to the
medical specialist in the two hospitals in the study, visits to
local physiotherapists and respiratory nurses in the hospital
and visits to local dieticians and units of Respifor R© used
were based on registrations. The travel expenses for visits
obtained from the registrations were calculated based on the
average distance to the healthcare provider (hospital: 7.0, lo-
cal physiotherapist: 1.8 and local dietician: 3.9 kilometers)
(11). Data on visits to other care providers, use of over-the-
counter medication and medical devices, ambulance rides,
time lost from paid work, hours of (un)paid household help,
travel expenses for visits to other care providers and use of
other nutritional supplements besides Respifor R© were based
on the cost booklet, because data from registrations were not
available for these data sources.
Statistical Analyses
All randomized patients who had at least one outcome mea-
surement after start of treatment and completed at least one
cost booklet were included in this study. Missing data could
be the result of drop-out or unavailability of registrations or
cost booklets while patients were (still) in the trial. The per-
centage of missing data for the different data sources was
calculated as the total number of weeks with missing data
summed over all patients divided by the maximum number
of observable weeks if all patients had complete data for the
entire 2-year study period (=18200).
Correlation between resource use data from the regis-
tration and self-reported resource use from the cost booklet
was calculated using Spearman’s rank correlation coefficient
(rho). Furthermore, the proportion of perfect agreement be-
tween the two data sources was determined, where perfect
agreement was defined as no difference between the two
data sources. The correlation between the registrations and
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the cost booklet was calculated for the whole 2-year period,
but also for 0 to 4 months, 4 to 12 months, and 12 to 24
months to see whether correlation changes over time.
After valuation of resource use, the absolute difference
in total costs was calculated for each patient as the total
costs based on the registrations minus the total costs based
on the cost booklet. Multivariate linear regression analysis
with the absolute difference in costs as depend variable was
performed to investigate whether treatment group, drop-out,
gender, age, number of co-morbidities at baseline, disease
severity, health status, and total costs were associated with
either under- or overreporting. Underreporting was defined
as higher costs based on the registrations compared with
the cost booklet, while overreporting was defined as higher
costs as obtained from the cost booklet compared with the
registrations. In these analyses, data from patients who did
not complete the full 2 years of the trial were included in the
analyses up until the moment patients dropped out and no
imputation of missing data was done.
To account for costs and health outcomes that were miss-
ing due to drop-out and the additional uncertainty that these
missing values introduce, “multiple imputation” was applied
before calculating the cost-utility (16). This was done sepa-
rately for missing costs based on self-reported resource use
from the cost booklet and missing costs based on resource use
from registrations. Each missing value was replaced by ten
simulated values using the propensity score method in SAS
V8 (10;15). Missing EQ-5D scores were imputed simultane-
ously with costs. More details about the multiple imputation
are described elsewhere (7).
Each of the ten complete datasets was further analyzed
by nonparametric bootstrapping using 10,000 replications
per dataset (3). The 2.5th percentile and the 97.5th percentile
of these bootstrap replications form the 95 percent confi-
dence interval of the difference in costs and QALYs. The
uncertainty around the point estimates of the incremental
cost-effectiveness ratios (ICERs) was displayed by plotting
the bootstrap replications in cost-effectiveness planes (CE-
planes). In addition, cost-effectiveness acceptability curves
were drawn, which show the probability that the INTERCOM
program is cost-effective at several values of the willingness-
to-pay for one additional QALY (5;19). All analyses were
performed with either SPSS version 13.0 or SAS V8.
RESULTS
Subjects
In total, 175 of the 199 randomized patients were included
in this cost-effectiveness study, because they had at least
one outcome measurement after start of treatment and com-
pleted at least one cost booklet. Mean age was 67 years (SD
7), 26 percent was female, FEV1 percent predicted was 60
percent (SD 16), EQ-5D utility index score at baseline was
0.80 (SD 0.18), and patients had on average 1.5 (SD 1.5) co-
morbidities at baseline. Baseline characteristics of patients in
the INTERCOM and the usual care group were comparable.
Of the eighty-seven patients in the INTERCOM group that
were included, all visited the physiotherapist and the respi-
ratory nurses and twenty-one received additional nutritional
advice and Respifor R©. One hundred fifty-eight patients com-
pleted the 2-year study period; 75 percent in the INTERCOM
group and 84 percent in the usual care group, which was not a
statistically significant difference. Drop-outs in the INTER-
COM group had a significantly shorter length of stay in the
trial than drop-outs in the usual care group. Besides that,
drop-out in the INTERCOM group was related to a more im-
paired health status compared with completers, which was
not the case in the usual care group.
Availability of Data
Information about hospitalizations and outpatient visits to
medical specialists obtained from hospital records was avail-
able for 171 patients (97.7 percent). All other registrations
were 100 percent complete. Eighty-three percent of the 158
patients who completed the study filled in the cost booklet
for the exact two year period, while the remaining seventeen
percent missed on average 2.6 weeks. The missing number of
cost booklets in drop-outs was higher. Seventy-one percent
of the seventeen drop-outs did not complete the cost book-
lets until their formal date of drop-out with an average of 8.3
weeks missing. After the formal date of drop-out the number
of weeks with missing data was on average 37.8 per patient.
For all data sources, the total percentage of missingness was
below 10 percent (Table 1).
Agreement
For all types of resource use, the mean unimputed resource
use as obtained from the registrations was higher, except
for visits to the physiotherapist, for which the mean num-
ber of visits obtained from the cost booklet was slightly
higher (Table 1). Agreement was almost perfect for number
of COPD-related and total hospital admissions, number of
COPD-related and total hospital days and number of visits
to the physiotherapists (all rho > 0.8). Agreement was sub-
stantial for visits to the medical specialists, the respiratory
nurse, and the dietician and the number of units Respifor R©
used (rho > 0.6), while agreement for COPD-related and
total daycare treatment was moderate (rho > 0.4). The per-
centage of perfect agreement decreased as the mean resource
use increased. Agreement did not worsen or improve over
time (Supplementary Table 2, which can be viewed online at
www.journals.cambridge.org/thc).
Variables Related to Differences in Cost
Based on Self-report or Care Provider
Registrations
Comparison of the total unimputed costs between the two
data sources showed that 106 of 175 patients (61 percent)
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Table 2. Mean Costs per Patient for Different Categories of Care Based on Care Provider Registrations or the Self-reported
Cost Booklet after Multiple Imputation of Missing Data (in 2007 euros)
Difference in costs INTERCOM
and usual care (95%
INTERCOM (n = 87) Usual care (n = 88) confidence interval)
Care provider Self-reported Care provider Self-reported Care provider Self-reported
registrations cost booklet registrations cost booklet registrations cost booklet
General practitioner 162 162 175 175 −12 (−60 to 35) −13 (−61 to 34)
Medical specialist 582 571 738 609 −156 (−276 to −33) −38 (−175 to 102)
Physiotherapist 1,236 1,290 265 264 971 (834 to 1,104) 1,026 (882 to 1,168)
Dietician 81 70 20 20 62 (32 to 92) 50 (23 to 76)
Respiratory nurse 215 148 22 22 193 (171 to 215) 125 (106 to 145)
Hospital admissions 2,793 2,341 3,342 3,021 −549 (−2,204 to 1,204) −679 (−2,116 to 866)
Diet nutrition 340 318 31 31 309 (145 to 500) 287 (115 to 483)
Prescribed medication 3,525 3,528 3,313 3,321 212 (−243 to 665) 208 (−248 to 659)
Oxygen use 198 197 56 57 141 (−10 to 306) 141 (−11 to 305)
Other direct medical costsa 2,908 2,901 2,147 2,148 760 (−1,204 to 2,893) 754 (−1,231 to 2,889)
Costs paid by the patientb 386 424 486 491 −100 (−509 to 233) −67 (−475 to 266)
Productivity costs 996 983 330 330 667 (−123 to 1,563) 653 (−136 to 1,552)
Total costs 13,423 12,932 10,925 10,488 2,498 (−855 to 6,084) 2,444 (−819 to 5,950)
Note. Gray cells contain data obtained from the two different data sources. Data in white cells are based on the same data source either the self-reported cost
booklet or care provider registrations. Small differences in the white cells are the result of the multiple imputation procedure.
a Other direct medical costs included costs of visits to other therapists, alternative therapists, social workers and psychologists, home care, ambulance
transportation, pulmonary rehabilitation (daycare treatment and inpatient), psychiatric hospital admissions, and medical devices.
b Costs paid by the patient included costs of over-the-counter medication, paid and unpaid household help, and travel expenses.
were underreporting, that is, they had higher costs based on
the registrations compared with the cost booklet. Sixty-five
patients (37 percent) were overreporting, because they had
higher costs based on the cost booklets compared with the
registrations. For the remaining four patients, the absolute
difference between the two data sources could not be cal-
culated, because data for visits to the medical specialist and
hospitalizations were not available from the registrations. In
the multivariate linear regression, the degree of underreport-
ing was significantly independently associated with drop-out
and total costs. Patients who dropped out during the trial and
patients with higher total costs had larger differences in costs
between the registrations and the cost booklet compared with
patients who completed the study and patients with lower to-
tal costs, respectively. The degree of overreporting was only
associated with total costs with higher total costs resulting in
more overreporting. The association of drop-out with under-
reporting was confirmed using the logarithm of costs as the
dependent variable. No association was found with treatment
group, gender, age, number of co-morbidities at baseline,
health status, or indicators of disease severity.
Supplementary Figure 1, which can be viewed online
at www.journals.cambridge.org/thc, shows the difference in
costs between registrations and the cost booklet after mul-
tiple imputation. These are the final cost estimates used in
the cost-utility calculations. The cost difference was highest
for hospitalizations, approximately 390 euros and lowest for
visits to the dietician, approximately 50 euros.
Table 2 shows the mean costs by treatment group after
applying multiple imputation separately for costs based on
the registrations or the cost booklet. Costs for visits to the
physiotherapist, respiratory nurse, dietician and the use of
diet nutrition, all elements of the INTERCOM program, ob-
viously were significantly higher for the INTERCOM group,
irrespective of the data source used. Costs for visits to the
medical specialist were significantly higher in the usual care
group based on the registrations, while this was not the case
when costs were based on the cost booklet. However, dif-
ferences between the two data sources were small across all
types of resource use (Table 2).
The difference in total costs between the two treatment
groups was comparable for both data sources 2,498 euros
(95 percent confidence interval [CI], −88 to 6,084) based
on the registrations and 2,444 euros (95 percent CI, −819 to
5,950) based on the cost booklet. The gain in QALYs due to
the INTERCOM program was 0.08 (95 percent CI, −0.01 to
0.18). This resulted in ICERs of 29,390 euro/QALY based
on the registrations and 29,100 euro/QALY based on the
cost booklet. CE-planes for both data sources were similar
(Figure 1). For both the registrations and the cost booklet,
approximately 88 percent of the bootstrap replications fell
in the upper-right quadrant indicating that the INTERCOM
program has a higher gain in QALYs, but also higher costs.
The acceptability curves were also comparable. The prob-
ability that the INTERCOM program is cost-effective at a
willingness-to-pay of 20,000 and 50,000 euros per QALY
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Figure 1. Cost-effectiveness planes, cost per quality-adjusted life-year (QALY).
gained was in both data sources 37 percent and 69 percent,
respectively.
DISCUSSION
This study showed the impact of self-report or registration-
based resource use on costs and cost-utility. Agreement be-
tween self-reported resource use and resource use based
on registrations was good or substantial for most types of
care. Because inaccuracy increases with longer recall peri-
ods (1), the relatively short recall period in our study may
have contributed to this high agreement. The cost booklets
were designed to record resource use per week and each
booklet covered 4 weeks. The booklets were collected ev-
ery 2 months. This is a relatively short recall period com-
pared with other studies using recall periods of 6 or even
12 months (8;12;14;17). The high agreement between the
two data sources for hospital admissions/days were in accor-
dance with other studies showing a high agreement for major
events (1;8;17). The agreement for visits to the physiothera-
pist was higher than in other studies (6;13), probably because
the visits took place on a regular basis, two times a week in
the first 4 months and once a month thereafter. Agreement
for daycare treatment in hospital was poor. This may have
been related to the fact that the cost booklet did not explicitly
specify daycare treatment in hospital separately from inpa-
tient hospitalizations including an overnight stay. It identified
daycare treatment when the date of admission and discharge
was the same.
Our study confirmed that self-report results in underesti-
mation. For all categories of care, except one, mean resource
use was lower for the cost booklet than for the registrations.
Analyses of the difference in total costs based on either the
cost booklet or the registrations showed that both under- and
overreporting were associated with total costs. The associ-
ation between increased visit frequency and underreporting
was reported by several studies before (1;2;20). As total re-
source use increases patients are more likely to forget visits
or unwilling to write everything down. The relation between
increased visit frequency and overreporting has also been
found in other studies (12). With an increase of resource use,
it is more difficult to remember the exact date of a certain
visit. As a result visits that occurred outside the actual recall
period, may have been included.
The absolute difference in costs between the registra-
tions and the cost booklet was approximately 460 euros. De-
spite the almost perfect agreement for hospitalizations and
hospital days, the cost difference between the registrations
and self-reported resource use was highest for this type of
care, approximately 390 euros. For visits to the dietician the
cost difference was lowest, approximately 50 euros, although
agreement for this type of care between the two data sources
was only substantial. Hence, good agreement between self-
reported resource use and resource use from registrations
does not automatically result in good agreement in costs,
when unit costs are high. Van den Brink et al. also investi-
gated the effect of different data sources on costs for a limited
number of types of care (18). They found that cost estimates
for medication and stoma care products based on self-report
were substantially lower compared with providers’ records.
The cost estimates for hospital admissions however did not
differ much between the two data sources in contrast to what
we found in our study.
The observed difference in total costs of approximately
500 euros between the registrations and the cost booklet
within treatment groups did not have an influence on the
difference in costs between treatment groups. The cost dif-
ference between treatment groups was only slightly different,
2,498 euros based on registrations versus 2,444 euros based
on the cost booklet. As a result the CE-ratio, CE-planes and
acceptability curves were comparable.
A limitation of our study was that we did not have both
data sources for all types of resource use. Although it is
common in economic evaluations to combine resource use
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data obtained from different sources, it is unusual to have
multiple sources for a single type of resource use. It is not
common practice to validate resource use data obtained from
one source with a second source. We collected data from sev-
eral care provider registrations in addition to the data from
the cost booklet for the specific purpose to validate the book-
let. Of the two items with the highest costs in our study,
that is, medication and hospitalizations, only the latter was
available from both self-report and registrations. Informa-
tion on outpatient medication was only available from the
administrative systems of patients’ local pharmacies. Given
the length of the study, 2 years, and the large number of
different medications used by COPD patients, the choice for
registrations was made to limit the burden of data record-
ing by the patients. For other high costs categories, such as
“other direct medical costs” and “productivity costs,” getting
data from registrations would have been very difficult if not
impossible. However, if only items with two data sources
would have been included in the cost-effectiveness analy-
sis, the cost difference between treatment groups would have
been 730 euros based on registrations versus 704 euros based
on the cost booklet, resulting in ICERs of 8,590 and 8,379
euros/QALY, which would not have changed the conclusions.
The final estimate of costs used in the original cost-
effectiveness study was based on a combination of both
sources. Most resource use information was obtained from
the cost booklet except for outpatient medication and oxygen,
which were obtained from registrations. For hospitalizations
we combined both sources and counted all hospitalizations
irrespective of whether they were recorded by patients only,
in the registrations only or in both sources. This resulted
in higher costs for hospitalizations compared with the data
presented in this study and, therefore, in somewhat different
estimates for the cost difference between treatment groups
and the cost-effectiveness, 2,751 euros (95 percent CI, −632
to 6,372) and 32,425 euros/QALY, respectively (7).
In conclusion, we showed that self-reported resource
use led to different cost estimates than care provider regis-
trations, but it did so in both treatment groups. As a result,
estimates of the difference in costs between two treatment
groups and estimates of the cost-utility of the INTERCOM
program were comparable between the two methods of re-
source use measurement.
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